Health care in Russia: the nearest future great challenges

Bachinskaya Elena,Medical manager,

Janssen, Russia

Health care in Russia: general assumptions 2013-2014

Goals for Russian Pharma 2020: local R&D and production +

new federal medical insurance system

2013• Flat investments in out-patients drug provision programs• Growth of reimbursement market is driven by hospital segment• Prioritization for local drugs development and production• Treatment standards implementation• One-channel financing• Regions are responsible for medico-economical standards creation and

execution

2014• Decentralization of essential drug programs execution to regional level• Regional budget calculation based on per capita spending • National Drug Insurance: pilot regions 2014, implementation in 2015-2016

4 main innovations will ensure competitiveness of new health care system

Specification of standards of medical care and related measures to improve the economic efficiency

Transition to a single channel financing through the Federal mandatory health insurance fund

Expansion of financing of a limited number of medical institutions and the freedom of choice of medical institutions for patients

Strengthening of regional autonomy in making decisions on the issues of health and complication access to market for new players

Health care financing will shift to the Unified national funding organization

Source of expenses in health care, billions $

Government budget

National insurance Personal expenses

14% per year

Ascher J et al. Russian health care evolution. McKinsey Bulletin, Moscow, 2012

How to be prepared to the reforms: my role in medium term view

Enhance scientific and clinical competitive advantages for products and company to customers expectations

Create new health care professionals management approach based on systematic development and maintenance of customer relationships for increasing their satisfaction and loyalty (from customer to integrated partner)

Establish professional Medical affairs support as a important competence for pharma company

Rebuild medical information management

Pharma company portfolio management for budget segments access: shift from central to regional execution

New working approach with external and internal customers